FLT3 and acute myeloid leukemia: Over a long-term follow-up period of 60 months, survival, outcome, and the likelihood of relapse were similar in AML patients with and without NPM1mut, and this is because NPM1mut are significantly associated with normal karyotypes and FLT3-ITD mutations (Table 2).